EDGAR Filing Documents for 0001104659-22-062504

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001104659-22-062504

Filing Date

2022-05-18

Accepted

2022-05-18 17:11:06

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	tm2215771-1_s3.htm	S-3	620435
2	EXHIBIT 1.2	tm2215771d2_ex1-2.htm	EX-1.2	266799
3	EXHIBIT 4.3	tm2215771d2_ex4-3.htm	EX-4.3	390813
4	EXHIBIT 4.5	tm2215771d2_ex4-5.htm	EX-4.5	120235
5	EXHIBIT 4.6	tm2215771d2_ex4-6.htm	EX-4.6	117958
6	EXHIBIT 4.7	tm2215771d2_ex4-7.htm	EX-4.7	99043
7	EXHIBIT 5.1	tm2215771d2_ex5-1.htm	EX-5.1	34041
8	EXHIBIT 23.1	tm2215771d2_ex23-1.htm	EX-23.1	2409
9	EX-FILING FEES	tm2215771d2_ex-filingfees.htm	EX-FILING FEES	48048
10	GRAPHIC	tm2215771d2_ex5-1img001.jpg	GRAPHIC	3120
11	GRAPHIC	lg_gaintherapeutics-4c.jpg	GRAPHIC	29589
12	GRAPHIC	tm2215771d1-fc_product4c.jpg	GRAPHIC	63827
	Complete submission text file	0001104659-22-062504.txt		1834199

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814

Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556

Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)